Evidence map›Paper›PMID 30268942›Full record

ArticleNeoplasia (New York, N.Y.)2018

MiPanda: A Resource for Analyzing and Visualizing Next-Generation Sequencing Transcriptomics Data.

Yashar S Niknafs, Balaji Pandian, Tilak Gajjar, Zach Gaudette, Kevin Wheelock, Mitra P Maz, Rohan K Achar, Melinda Song, Cory Massaro, Xuhong Cao and 1 more

Abstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. UALCAN Mobile, an app for cancer proteogenomic data analysis.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Breast cancer associated CD169Frontiers in immunology · 2023
    Article
  6. Context-Dependent Function of Long Noncoding RNAMolecular and cellular biology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Characterization ofFrontiers in genetics · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yashar S NiknafsMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Balaji PandianMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Tilak GajjarMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Zach GaudetteMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Kevin WheelockMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Mitra P MazMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Rohan K AcharMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Melinda SongMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Cory MassaroMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. Electronic address: arul@med.umich.edu.

Funding

Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Timothy Dess · 2014 to 2026
$27.6M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Exploring Precision Oncology: From Gene Fusions to lncRNAsR35CA231996 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M · 2018 to 2024
$6.4M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancerU01CA214170 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M · 2016 to 2021
$3.3M
NCI NIH HHS P50 CA186786NCI NIH HHS R35 CA231996NCI NIH HHS U01 CA214170NCI NIH HHS U24 CA210967NIGMS NIH HHS T32 GM007315
6 · The paper itself

Abstract

The Michigan Portal for the Analysis of NGS data portal (http://mipanda.org) is an open-access online resource that provides the scientific community with access to the results of a large-scale computational analysis of thousands of high-throughput RNA sequencing (RNA-seq) samples. The portal provides access to gene expression profiles, enabling users to interrogate expression of genes across myriad normal and cancer tissues and cell lines. From these data, tissue- and cancer-specific expression patterns can be identified. Gene-gene coexpression profiles can also be interrogated. The current portal contains data for over 20,000 RNA-seq samples and will be continually updated.

Indexed as

High-Throughput Nucleotide SequencingSoftwareTranscriptomeComputational BiologyHumansSequence Analysis, DNA

Identifiers

PMID30268942
PMCPMC6171536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.